Your Health Plan:
YUFLYMA (adalimumab) is a biosimilar prescription drug for treatment of Rheumatoid Arthritis, Juvenile arthritis, Juvenile polyarthritis, Arthritis, Psoriatic, Ankylosing spondylitis, Crohn Disease, Ulcerative Colitis, Psoriasis and Hidradenitis Suppurativa. YUFLYMA is a tumor necrosis factor blocker. It is available in the form of subcutaneous injection.
See full Prescribing Information for important safety information and clinical studies.
YUFLYMA is not covered by . Cash price for 30-day supply is $2700-6900.
Patient Assistance Prorgams and Coupons are found:
Other alternatives to YUFLYMA may include:
